Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the placement of ...

“We’re honored to support the Broad Institute’s commitment to science by enabling access to Platinum Pro,” said Jeff Hawkins, President and Chief Executive Officer of Quantum-Si.

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today ...

Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives Business Wire Jun 24, 2025 ...

About Quantum-Si Incorporated Quantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere.

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum ...

Quantum-Si (NasdaqGM:QSI) recently launched its innovative benchtop sequencer, Platinum® Pro, designed to expand access to advanced proteomics tools globally. However, despite this significant product ...

John S. Vieceli, Chief Product Officer at Quantum-Si Inc (NASDAQ: QSI), sold 21,923 shares of Class A Common Stock on June 23, 2025, according to a Form 4 filing with the Securities and Exchange ...

Melissa Deck from Liberate Bio is set to present on the use of Quantum-Si’s Platinum Pro instrument in drug development.

Quantum-Si has also announced its participation in the upcoming Festival of Genomics & Biodata Boston, where it will showcase advancements in its protein sequencing technology. Melissa Deck from ...

Quantum-Si continues to focus on technological advancements, with plans to launch its Proteus platform in the latter half of 2026. In addition, the company is set to showcase its protein sequencing ...